Inactive

The U. S. Food & Drug Administration, (FDA) Office of Acquisition and Grants Services (OAGS) has a requirement for the Relocation of Orbitrap Fusion and Q-Exactive LC-MS Systems and perform post-move ... The U. S. Food & Drug Administration, (FDA) Office of Acquisition and Grants Services (OAGS) has a requirement for the Relocation of Orbitrap Fusion and Q-Exactive LC-MS Systems and perform post-move preventative maintenance (PM) and IQ/OQ for these systems and performance verification.